The Ameliorative Effect of Rubi Fructus on DSS-induced Colitis in Mice

Noh-Yil Myung

doi:10.7732/kjpr.2021.34.3.216

All Issue

2021 Vol.34, Issue 3 Preview Page Next Page

Research Article

The Ameliorative Effect of Rubi Fructus on DSS-induced Colitis in Mice

31 May 2021. pp. 216-222

PDF XML

Abstract

Ulcerative colitis (UC) is an inflammatory bowel disease and a chronic gastrointestinal disorder. Rubi Fructus (RF), the fruit of Rubus coreanus Miquel, is known to exert several pharmacological effects including anti-oxidative, anti-obesity and anti-inflammatory properties. However, the improving effect and mechanism of RF on intestinal inflammation is not been fully understood. The purpose of this study was to investigate the regulatory effect of RF on dextran sulfate sodium (DSS)-induced colitis in mice. We evaluated the effects of RF on DSS-induced clinical signs by analyzing weight loss and colon length. The inhibitory effects of RF on inflammatory mediators such as prostaglandin E₂ (PGE₂), cyclooxygenase (COX)-2, as well as the activation of nuclear factor-κB (NF-κB), were determined in colitis tissue. Our data indicated that mice treated with DSS showed clinical symptoms of colitis, including weight loss, colon length decrease and diarrhea. However, we observed that RF treatment significantly improved these clinical symptoms of weight loss, colon length decrease and diarrhea induced by DSS. RF inhibited the enhanced levels of COX-2 and PGE₂ caused by DSS. We also showed that the anti-inflammatory mechanism of RF by suppressing the activation of NF-kB in DSS-treated colon tissues. Collectively, the findings of this study indicate the prospect of developing new drugs from RF for UC treatment.

Keywords

Dextran sulfate sodium

Nuclear factor-κB

Rubi fructus

Ulcerative colitis

References

Agoff, S.N., T.A. Brentnall, D.A. Crispin, S.L. Taylor, S. Raaka, R.C. Haggitt, M.W. Reed, I.A. Afonina, P.S. Rabinovitch, A.C. Stevens, Z. Feng and M.P. Bronner. 2000. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am. J. Pathol. 157:737-745. 10.1016/S0002-9440(10)64587-7

Ardizzone, S. and P.G. Bianchi. 2005. Biologic therapy for inflammatory bowel disease. Drugs 65:2253-2286. 10.2165/00003495-200565160-0000216266194

Atreya, I., R. Atreya and M.F. Neurath. 2008. NF-kappa B in inflammatory bowel disease. J. Intern. Med. 263:591-596. 10.1111/j.1365-2796.2008.01953.x18479258

Baumgart, D.C. and S.R. Carding. 2007. Inflammatory bowel disease: Cause and immunobiology. Lancet 369:1627-1640. 10.1016/S0140-6736(07)60750-8

Danese, S., M. Sans and C. Fiocchi. 2004. Inflammatory bowel disease; the role of environmental factors. Autoimmun. Rev. 3:394-400. 10.1016/j.autrev.2004.03.00215288007

Domenech, E. 2006. Inflammatory bowel disease: Current therapeutic options. Digestion 73:67-76. 10.1159/00008978116498254

Ferrer, M.D., C. Busquets-Cortés, X. Capó, S. Tejada, J.A. Tur, A. Pons and A. Sureda. 2019. Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr. Med. Chem. 26:3225-3241. 10.2174/092986732566618051411212429756563

He, J.M., S.C. Chen, R.P. Li, L.X. Yuan, J.M. Bao and M.L. Guo. 2015. Suppression of nuclear factor-kappa B and mitogen-activated protein kinase signalling pathways by goshonoside-F5 extracted from Rubi Fructus. Int. Immunopharmacol. 24:182-190. 10.1016/j.intimp.2014.12.00725523460

Hendrickson, B.A., R. Gokhale and J.H. Cho. 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin. Microbiol. Rev. 15:79-94. 10.1128/CMR.15.1.79-94.200211781268PMC118061

Hudcovic, T., R. Stepankova, J. Cebra and H. Tlaskalova-Hogenova. 2001. The role of microflora in the development of intestinal inflammation: Acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbio. 46:565-572. 10.1007/BF0281800411898350

Jeong, M.Y., H.L. Kim, J. Park, Y. Jung, D.H. Youn, J.H. Lee, J.S. Jin, H.S. So, R. Park, S.H. Kim, S.J. Kim, S.H. Hong and J.Y. Um. 2015. Rubi Fructus (Rubus coreanus) activates the expression of thermogenic genes in vivo and in vitro. Int. J. Obes. (Lond). 39:456-464. 10.1038/ijo.2014.15525109782

Jung, S.H., H.Y. Yu, J.H. Seo, Y.J. Lee and M.W. Han. 2021. A study on the comparison of chemical characterization and ellagic acid content between distribution Bokbunja and Korean Native Bokbunja. Korean J. Plant Res. 34:177-185.

Li, Y., C. Soendergaard, F.H. Bergenheim, D.M. Aronoff, G. Milne, L.B. Riis, J.B. Seidelin, K.B. Jensen and O.H. Nielsen. 2018. COX-2-PGE(2) signaling impairs intestinal epithelial regeneration and associates with TNF inhibitor responsiveness in ulcerative colitis. EBioMedicine 36:497-507. 10.1016/j.ebiom.2018.08.04030190207PMC6197735

Lin, X., Q. Sun, L. Zhou, M. He, X. Dong, M. Lai, M. Liu, Y. Su, C. Jia, Z. Han, S. Liu, H. Zheng, Y. Jiang, H. Ling, M. Li, J. Chen, Z. Zou and X. Bai. 2018. Colonic epithelial mTORC1 promotes ulcerative colitis through COX-2-mediated Th17 responses. Mucosal. Immunol. 11:1663-1673. 10.1038/s41385-018-0018-330082707

Nam, M.K., H.R. Choi, J.S. Cho, S.M. Cho, K.C. Ha, T.H. Kim, H.Y. Ryu and Y.I. Lee. 2014. Inhibitory effects of Rubi Fructus extracts on hepatic steatosis development in high-fat diet-induced obese mice. Mol. Med. Rep. 10:1821-1827. 10.3892/mmr.2014.239825050832

Periasamy, S., W.H. Wu, S.P. Chien, C.T. Liu and M.Y. Liu. 2020. Dietary Ziziphus jujuba fruit attenuates colitis-associated tumorigenesis: A pivotal role of the NF-kappaB/IL-6/JAK1/STAT3 pathway. Nutr. Cancer. 72:120-132. 10.1080/01635581.2019.161551531135224

Ramakers, J.D., M.I. Verstege, G. Thuijls, A.A. Te Velde, R.P. Mensink and J. Plat. 2007. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J. Clin. Immunol. 27:275-283. 10.1007/s10875-007-9074-217510806PMC1915631

Roberts, P.J., K. Morgan, R. Miller, J.O. Hunter and S.J. Middleton. 2001. Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease. Gut 48:468-472. 10.1136/gut.48.4.46811247889PMC1728255

Rogler, G., K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P.A. Baeuerle, J. Schölmerich and V. Gross. 1998. Nuclear factor kappa B is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115:537-569. 10.1016/S0016-5085(98)70202-1

Sandborn, W.J. and S.R. Targan. 2002. Biologic therapy of inflammatory bowel disease. Gastroenterology 122:1592-1608. 10.1053/gast.2002.3342612016425

Skupsky, J., S. Sabui, M. Hwang, M. Nakasaki, M.D. Cahalan and H.M. Said. 2020. Biotin supplementation ameliorates murine colitis by preventing NF-kappaB activation. Cell. Mol. Gastroenterol. Hepatol. 9:557-567. 10.1016/j.jcmgh.2019.11.01131786364PMC7078531

Tak, P.P. and G.S. Firestein. 2001. NF-κB: A key role in inflammatory disease. J. Clin. Invest. 107:7-11. 10.1172/JCI1183011134171PMC198552

Tsuge, K., T. Inazumi, A. Shimamoto and Y. Sugimoto. 2019. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. 2019. Int. Immunol. 31:597-606. 10.1093/intimm/dxz02130926983

Wirtz, S., V. Popp, M. Kindermann, K. Gerlach, B. Weigmann, S. Fichtner-Feigl and M.F. Neurath. 2017. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12:1295-1309. 10.1038/nprot.2017.04428569761

Yashiro, M. 2014. Ulcerative colitis-associated colorectal cancer. World. J. Gastroenterol. 20:16389-16397. 10.3748/wjg.v20.i44.1638925469007PMC4248182

Information

Publisher :The Plant Resources Society of Korea
Publisher(Ko) :한국자원식물학회
Journal Title :Korean Journal of Plant Resources
Journal Title(Ko) :한국자원식물학회지
Volume : 34
No :3
Pages :216-222
Received Date : 2021-05-17
Revised Date : 2021-05-24
Accepted Date : 2021-05-24
DOI :https://doi.org/10.7732/kjpr.2021.34.3.216

Korean Journal of Plant Resources ISSN:1226-3591(Print) 2287-8203(Online) 한국자원식물학회지

All Issue